Prognostic value of 6-minute walk test and cardiopulmonary exercise test in acute heart failure (from the ESCAPE trial).
6-minute walk test
Cardiopulmonary exercise test
Heart failure
Mortality
Rehospitalization
Journal
American heart journal plus : cardiology research and practice
ISSN: 2666-6022
Titre abrégé: Am Heart J Plus
Pays: United States
ID NLM: 101779333
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
30
09
2020
revised:
13
03
2021
accepted:
16
03
2021
medline:
20
3
2021
pubmed:
20
3
2021
entrez:
1
4
2024
Statut:
epublish
Résumé
We aim to study the utility of 6-minute walk distance (6MWD) and cardiopulmonary exercise testing (CPET) in patients with acute systolic heart failure (HF) in predicting post-discharge outcomes. The ESCAPE trial data was utilized to examine the prognostic role of 6MWD and CPET in predicting 6-month all-cause mortality and rehospitalization in acute HF. The average 6MWD recorded in 271 and 292 patients on admission and discharge was 597 and 765 ft., respectively. Compared with non-survivors, survivors had significantly higher 6MWD on admission (624 vs. 463 ft., 6MWD is an independent mortality determinant in advanced systolic HF.
Identifiants
pubmed: 38560362
doi: 10.1016/j.ahjo.2021.100005
pii: S2666-6022(21)00003-3
pmc: PMC10976288
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100005Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.